Minimed Group (MMED) reported $3.1B in revenue for fiscal 2025, +14.3% year on year. That ranks #1079 by revenue among 2853 SEC filers and #95 in Healthcare. It posted a net loss of −$333M for the same year. Revenue has grown 12.1% a year on average since 2023 ($2.5B then). The fiscal 2025 balance sheet shows $4.3B in total assets and $10.0M in cash.

Key figures

$2.5B2023$2.7B2024$3.1B2025
Minimed Group — Key figures
Key figuresFY2025YoYSource
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$3.1B+14.3%FY20252026-04-24
Gross profitGrossProfit$1.7B+9.9%FY20252026-04-24
Operating incomeOperatingIncomeLoss−$190M−$44.0MFY20252026-04-24
Net incomeNetIncomeLoss−$333M−$120MFY20252026-04-24
Operating cash flowNetCashProvidedByUsedInOperatingActivities−$197M−$337MFY20252026-04-24
Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment$223M+15.5%FY20252026-04-24
Total assetsAssets$4.3B—FY20252026-01-23
Shareholders' equityStockholdersEquity$3.5B−0.7%FY20252026-01-23
CashCashAndCashEquivalentsAtCarryingValue$10.0M0.0%FY20252026-01-23
Long-term debtNot reported—

Revenue is total net sales for the fiscal year, taken from each company's own annual filing.

Reported since the last full year

Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.

Minimed Group — Reported since the last full year
QuarterRevenueNet incomeSource
Q2 20262026-07-31$843M$0Open →

Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.

Where this sits in its sector

Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.

Minimed Group — Where this sits in its sector
Where this sits in its sectorFY2025Position in sector
Net marginRank 144 of 161 companies compared−10.7%
Operating marginRank 140 of 160 companies compared−6.1%
R&D as share of revenueRank 37 of 102 companies compared14.4%
Cash as share of revenueRank 160 of 160 companies compared0.3%

All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.

Profile

Legal name
Minimed Group, Inc.
Ticker
MMED
Exchange
Nasdaq
SIC classification
Surgical & Medical Instruments & Apparatus (3841)
Fiscal year end
12-31
CIK
0002062583

Filings

Similar in size, same sector

CompanyRevenueNet income
Biomarin PharmaceuticalBMRN$3.2B$349M
Brookdale Senior LivingBKD$3.2B−$263M
United TherapeuticsUTHR$3.2B$1.3B
Minimed GroupMMED$3.1B−$333M
West Pharmaceutical ServicesWST$3.1B$494M
Amneal PharmaceuticalsAMRX$3.0B$72.1M
Globus MedicalGMED$2.9B$538M

See the full ranking →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Minimed Group — Key figures |url=https://companiesranked.com/en/company/minimed-group |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Minimed Group — Key figures. CompaniesRanked. https://companiesranked.com/en/company/minimed-group

BibTeX

@misc{companiesranked-en-company-minimed-group-2026,
  author       = {{CompaniesRanked}},
  title        = {{Minimed Group — Key figures}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/minimed-group}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.